topiramate
topiramate: sourced relationships with 1 company · 4 clinical trials tracked · 1 FDA decision.
topiramate evidence translation
What we can confirm
1 FDA record · 4 tracked trials
What it means
What to watch
Prepared research question
How could topiramate → RDY affect its developer, and what evidence supports the link?
Traceable citations · Unknowns marked
See linked entities and source evidence2 indications · 2 study sponsors
Dated Pipeline Records (1)
| Company | Dated record stage |
|---|---|
| DR REDDYS LABORATORIES LTD (RDY) Reported 2023-11-17 · Current development: unknownSource | Approved |
Clinical Trial Registry Records (4)
A Comparative Effectiveness Study of Oral Medications Used for Migraine Prevention: The APT Comparison Study
Primary endpoint: Treatment Responder (atogepant vs. topiramate; atogepant vs. propranolol)
A Randomized, Double-Blind, Parallel-Group, Active Controlled Trial With Open-Label Safety Extension to Evaluate the Tolerability, Safety, and Efficacy of Atogepant Versus Topiramate in Subjects Requiring Preventive Treatment of Migraine (TEMPLE)
Primary endpoint: Percentage of Participants Who Discontinued Treatment Due to Treatment-Emergent Adverse Events (TEAEs)
Effectiveness of Semaglutide 2.4 mg vs. Commercially Available Medications for Chronic Weight Management in Participants With Obesity in a Multi-employer Setting in The US - a Pragmatic Clinical Study
Primary endpoint: Number of Participants Who Achieved Greater Than or Equal to (≥) 10.0 Percent (%) Body Weight Reduction (Yes/no)
Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants
Primary endpoint: M/P ratio
Frequently asked questions
Which companies have sourced relationships with topiramate?
topiramate has dated SEC/FDA relationship records for DR REDDYS LABORATORIES LTD.
How many clinical trials involve topiramate?
BioSniper tracks 4 clinical trials involving topiramate.
What is topiramate's latest FDA decision?
The most recent tracked FDA decision for topiramate is Approval, dated November 17, 2023.